ClinicalTrials.gg
CompletedNCT06201845Updated Oct 15, 2024

Assessment of Physical Activity Awareness Training in Healthy Young Adults

An interventional study of Exercise awareness training and physical activity awareness training in Healthy, sponsored by Istanbul Medipol University Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-15.

Sponsored by Istanbul Medipol University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

According to the World Health Organization, physical activity is defined as any bodily movement produced by skeletal muscles that requires energy expenditure. Positive effects of leading a physically active life and exercise have been shown in many areas ranging from diabetes to cardiovascular diseases, cancer to mortality, pain to autoimmunity .

Read the detailed description

Despite the many proven benefits of regular aerobic exercise, physical inactivity remains an important public health problem. In young adults, the perception that exercise is not fun and lack of time for exercise have led to a decrease in physical activity participation . However, studies in the literature have reported that after first creating awareness in individuals about the effects of physical activity on health, creating the necessary time for exercises provides sufficient motivation for individuals to start and continue a more active life.

02

Conditions studied

  • Healthy

Browse trials for

Keywords

  • exercise
03

In context

Motor Activity

2,649 studies on the registry are indexed under Motor Activity; 1,205 are open to participants now.

This study's enrollment of 60 is close to the median of 60 across 2,309 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Istanbul Medipol University Hospital is the lead sponsor of 365 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18-25 years of age.
  • Being cooperative.
  • Voluntarily participating in the study
  • Obtaining informed consent from them (Annex-1)

Exclusion criteria

Exclusion criteria:

  • Serious musculoskeletal disorders (disc herniation, etc. orthopedic or neurological diagnosis)
  • Having a serious systemic disease
  • Having a serious injury in the last 3 months.
  • Having any neurological problem.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Exercise awareness training

    Other: Exercise awareness training

  • Active comparator
    physical activity awareness training

    physical activity awareness training,

    Other: physical activity awareness training

Interventions

  • OtherExercise awareness training

    Group exercise training will consist of aerobic exercises including warm-up and cool-down exercises accompanied by music, and trunk strengthening training consisting of core exercises.

  • Otherphysical activity awareness training

    In the physical activity awareness training, the benefits of exercises on systemic, psychological effects and general body health will be explained and they will be informed about different exercise practice.

06

What researchers measure

Primary outcomes

  1. Jump

    The jump assesses explosive force through a standing long jump. Participants start from a designated point and jump forward without touching the line, measuring the distance in centimeters from the front of the jumping line to the point where the body's last contact occurred. It's crucial not to lift the feet before jumping, and at least two attempts are made to achieve the best distance.

    Time frame: 10 weeks

  2. Grip Strength Assessment

    Using a JAMAR hand dynamometer, grip strength for both dominant and non-dominant hands is measured during isometric contractions. Participants sit with shoulder adduction, elbow at 90° flexion, and forearm and wrist in a neutral position, gripping and squeezing the dynamometer with maximum force. The test is repeated three times, recording the highest reading in kilograms of force.

    Time frame: 10 weeks

  3. Plank Test

    Assesses the control, strength, and endurance of stabilizing core and back muscles. It's a vital exercise for training the endurance of rectus abdominis and external oblique abdominis muscles. The test shows excellent reliability in evaluating core strength and endurance

    Time frame: 10 weeks

  4. Modified Closed Kinetic Chain Upper Extremity Stability Test

    This test identifies deficits in functional performance of the upper extremity in closed kinetic chain positions. It involves a person assuming a push-up position and rapidly touching one hand's dorsal side to the other hand's dorsum within 15 seconds, aiming to maintain parallel alignment with the ground. The evaluator counts the correct hand touches, and the average of three maximal attempts determines the score.

    Time frame: 10 weeks

Secondary outcomes

  1. Sit-Up Test

    Measures abdominal muscle endurance by performing as many sit-ups as possible within 60 seconds. Participants lie on their backs, knees slightly bent, and hands placed parallel to the ground with palms facing downwards. They aim to touch their knees with their elbows while lifting their upper body without support from the hands

    Time frame: 10 weeks

07

Study locations

1 site
  • Bahçehir University
    Istanbul, Turkey (Türkiye)
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2024 to primary completion in Mar 2024, 2 months.

Of 1,726 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 47. This study's 2 months is below that.

Counting every sponsor, half of 1,738 studies reached it within 23 months; a quarter within 9 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 2, 2024
First posted
Jan 11, 2024
StartActual
Jan 15, 2024
Primary completionActual
Mar 15, 2024
CompletionActual
Sep 21, 2024
Last update
Oct 15, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06201845
Responsible party
hazal genc (Principal Investigator, Istanbul Medipol University Hospital) — Principal investigator
First posted
Jan 11, 2024
Start date
Jan 15, 2024
Primary completion
Mar 15, 2024
Completion
Sep 21, 2024
Last update
Oct 15, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion